Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin Effects on Visual Perception and Brain Representations
NCT05265546Phase 1Recruiting
- Sponsor
- University of California, Berkeley
- Start
- Mar 2024
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1 trial of psilocybin (2 arms), sponsored by University of California, Berkeley. Primary endpoint: Amplitude and pattern of fMRI cortical responses up to 2 hours. Started Mar 2024; status: recruiting.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT05265546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05265546.